Stay updated with breaking news from Diagnostics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lucid Diagnostics Inc. (NASDAQ:LUCD – Get Rating) was the target of a large growth in short interest in April. As of April 30th, there was short interest totalling 160,900 shares, a growth of 32.2% from the April 15th total of 121,700 shares. Based on an average trading volume of 92,000 shares, the days-to-cover ratio is […]
Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Rating) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.75 and traded as low as $0.75. Accelerate Diagnostics shares last traded at $0.75, with a volume of 227,371 shares trading hands. Wall Street Analyst Weigh In Separately, StockNews.com […]
Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Rating)’s stock price passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.75 and traded as low as $0.75. Accelerate Diagnostics shares last traded at $0.75, with a volume of 227,371 shares. Analysts Set New […]
/PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the first quarter for the period ended March 31, 2023. "Our...
/PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...